WBA vs. DNA

Last updated Apr 1, 2026

Compare and contrast key facts about Walgreens Boots Alliance, Inc. (WBA) and Ginkgo Bioworks Holdings, Inc. (DNA).

Performance

WBA vs. DNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Walgreens Boots Alliance, Inc. (WBA) and Ginkgo Bioworks Holdings, Inc. (DNA). The values are adjusted to include any dividend payments, if applicable.

WBA vs. DNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
WBA Walgreens Boots Alliance, Inc.	0.00%	28.40%	-61.34%	-25.09%	-25.06%	-0.28%
DNA Ginkgo Bioworks Holdings, Inc.	-26.23%	-15.38%	-85.47%	0.00%	-79.66%	-17.89%

Fundamentals

EPS WBA : -$7.28 DNA : -$5.65
PS Ratio WBA : 0.07 DNA : 1.99
Total Revenue (TTM) WBA : $154.58B DNA : $170.16M
Gross Profit (TTM) WBA : $26.47B DNA : $138.63M
EBITDA (TTM) WBA : -$2.92B DNA : -$215.86M

Returns By Period

WBA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

DNA

• 1D: 11.86%
• 1M: -9.19%
• YTD: -26.23%
• 6M: -57.96%
• 1Y: 7.54%
• 3Y*: -51.34%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

WBA vs. DNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DNA

DNA Risk / Return Rank: 46
DNA Sharpe Ratio Rank: 45
DNA Sortino Ratio Rank: 53
DNA Omega Ratio Rank: 51
DNA Calmar Ratio Rank: 42
DNA Martin Ratio Rank: 42

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WBA vs. DNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Walgreens Boots Alliance, Inc. (WBA) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	WBA	DNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.08	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.59	—

Correlation

The correlation between WBA and DNA is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WBA vs. DNA - Dividend Comparison

Neither WBA nor DNA has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
WBA Walgreens Boots Alliance, Inc.	0.00%	0.00%	10.72%	7.35%	5.13%	3.62%	4.64%	3.04%	2.46%	2.13%	1.78%	1.64%
DNA Ginkgo Bioworks Holdings, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

Drawdown Indicators

	WBA	DNA	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.10%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-66.05%	—
Current Drawdown Current decline from peak	—	-98.97%	—
Average Drawdown Average peak-to-trough decline	—	-78.98%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	32.41%	—

Volatility

Volatility by Period

	WBA	DNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	28.02%	—
Volatility (6M) Calculated over the trailing 6-month period	—	73.00%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	100.38%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	96.65%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	96.65%	—

Financials